Shenzhen New Industries Biomedical Engineering Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Shenzhen New Industries Biomedical Engineering has been growing earnings at an average annual rate of 19.4%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 19.5% per year. Shenzhen New Industries Biomedical Engineering's return on equity is 22.8%, and it has net margins of 41.7%.
Belangrijke informatie
19.4%
Groei van de winst
17.5%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 16.0% |
Inkomstengroei | 19.5% |
Rendement op eigen vermogen | 22.8% |
Nettomarge | 41.7% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?
Oct 14Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aug 25A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Jul 01Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Opbrengsten en kosten
Hoe Shenzhen New Industries Biomedical Engineering geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 4,436 | 1,851 | 795 | 422 |
30 Jun 24 | 4,275 | 1,807 | 761 | 398 |
31 Mar 24 | 4,075 | 1,725 | 794 | 384 |
31 Dec 23 | 3,930 | 1,654 | 747 | 366 |
30 Sep 23 | 3,658 | 1,590 | 608 | 366 |
30 Jun 23 | 3,495 | 1,508 | 582 | 357 |
31 Mar 23 | 3,180 | 1,375 | 490 | 342 |
01 Jan 23 | 3,047 | 1,328 | 478 | 318 |
30 Sep 22 | 2,948 | 1,233 | 507 | 296 |
30 Jun 22 | 2,737 | 1,115 | 495 | 262 |
31 Mar 22 | 2,756 | 1,114 | 505 | 233 |
01 Jan 22 | 2,545 | 974 | 530 | 215 |
30 Sep 21 | 2,518 | 906 | 626 | 180 |
30 Jun 21 | 2,451 | 892 | 634 | 155 |
31 Mar 21 | 2,439 | 997 | 603 | 163 |
31 Dec 20 | 2,195 | 939 | 515 | 151 |
30 Sep 20 | 2,065 | 911 | 484 | 147 |
30 Jun 20 | 1,911 | 910 | 427 | 143 |
31 Mar 20 | 1,655 | 745 | 397 | 120 |
31 Dec 19 | 1,682 | 773 | 393 | 119 |
31 Dec 18 | 1,384 | 694 | 306 | 84 |
31 Dec 17 | 1,141 | 538 | 243 | 56 |
31 Dec 16 | 923 | 452 | 246 | 0 |
30 Sep 16 | 867 | 380 | 276 | 0 |
30 Jun 16 | 811 | 307 | 306 | 0 |
31 Mar 16 | 771 | 278 | 299 | 0 |
31 Dec 15 | 732 | 249 | 292 | 0 |
30 Sep 15 | 677 | 264 | 226 | 0 |
30 Jun 15 | 623 | 279 | 160 | 0 |
31 Mar 15 | 584 | 266 | 149 | 0 |
31 Dec 14 | 545 | 253 | 138 | 0 |
30 Sep 14 | 506 | 224 | 134 | 0 |
30 Jun 14 | 467 | 194 | 130 | 0 |
31 Mar 14 | 423 | 168 | 120 | 0 |
31 Dec 13 | 378 | 141 | 110 | 0 |
Kwaliteitswinsten: 300832 has high quality earnings.
Groeiende winstmarge: 300832's current net profit margins (41.7%) are lower than last year (43.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 300832's earnings have grown by 19.4% per year over the past 5 years.
Versnelling van de groei: 300832's earnings growth over the past year (16.4%) is below its 5-year average (19.4% per year).
Winst versus industrie: 300832 earnings growth over the past year (16.4%) exceeded the Medical Equipment industry -8.8%.
Rendement op eigen vermogen
Hoge ROE: 300832's Return on Equity (22.8%) is considered high.